AUM News & Analysis

5 articles

Market Mood

3 Bullish2 Neutral0 Bearish
CIBRA Capital Acquires 1.48M Shares of Amicus Therapeutics (FOLD)
M&ABullish4/25/2026

CIBRA Capital Acquires 1.48M Shares of Amicus Therapeutics (FOLD)

CIBRA Capital Ltd increased its shareholding in Amicus Therapeutics (FOLD) by 1,476,861 shares, valued at approximately $21.17 million as per the SEC filing on April 24, 2026. The total value of this position rose to $24.40 million, accounting for 11.78% of CIBRA's reportable assets under management. This transaction reflects a 10.2% increase in assets and comes as Amicus shares were priced at $14.46, having achieved a 103.7% total return over the past year. Key products include therapies for rare diseases like Fabry and Pompe, contributing to $634.21 million in revenue.

Read More
VGIT vs IEI: Expense Ratios and Returns Compared in 2026
MarketsNeutral4/25/2026

VGIT vs IEI: Expense Ratios and Returns Compared in 2026

The Vanguard Intermediate-Term Treasury ETF (VGIT) has an expense ratio of 0.03% and a 1-year return of 4.6% as of April 22, 2026. In contrast, the iShares 3-7 Year Treasury Bond ETF (IEI) has an expense ratio of 0.15% and a 1-year return of 4.2%. VGIT's assets under management (AUM) are $48.5 billion, while IEI's AUM stands at $18.8 billion. Both ETFs exclusively hold U.S. Treasuries, but VGIT covers a maturity range of three to ten years, compared to IEI's narrower three to seven-year band.

Read More
CLOA ETF Sees 6.2M Shares Acquired by Richard Bernstein Advisors
EarningsBullish4/23/2026

CLOA ETF Sees 6.2M Shares Acquired by Richard Bernstein Advisors

Richard Bernstein Advisors LLC acquired 6,186,664 shares of the iShares AAA CLO Active ETF (CLOA) for approximately $320.66 million, representing 9.3% of the firm's assets under management (AUM) as of March 31, 2026. The ETF is priced at $51.85, down 0.36% from its 52-week high, with a one-year total return of 6.2%. This purchase positions CLOA among the top five holdings of the firm, indicating a strategic shift towards capital preservation and income generation through AAA-rated collateralized loan obligations. Richard Bernstein Advisors has reported a total of 227 positions and $3.45 billion in AUM.

Read More
iShares ETFs: IEMG and IEFA Comparison with Key Data Points
EarningsNeutral4/18/2026

iShares ETFs: IEMG and IEFA Comparison with Key Data Points

The iShares Core MSCI Emerging Markets ETF (IEMG) aims for emerging markets and has a 1-year return of 53.2% and an expense ratio of 0.09%. In contrast, the iShares Core MSCI EAFE ETF (IEFA), focusing on developed markets, offers a 1-year return of 33.9% and a lower expense ratio of 0.07%. IEMG has $134.1 billion in assets under management (AUM), compared to IEFA's $169.6 billion. Both ETFs serve distinct investment strategies, appealing to different risk tolerances and market exposures.

Read More
Stadium Capital Buys 72,000 Shares of LCI Industries Valued at $7.66 Million
MarketsBullish3/22/2026

Stadium Capital Buys 72,000 Shares of LCI Industries Valued at $7.66 Million

On February 17, 2026, Stadium Capital Management disclosed purchasing 72,000 shares of LCI Industries (NYSE:LCII) for an estimated $7.66 million, based on quarterly average pricing. This buy increased their total holdings in LCI to 167,923 shares, with a value of approximately $20.38 million, making up 23.6% of their 13F assets under management (AUM). LCI Industries reported $4.1 billion in annual revenue, net income of $188.25 million, and a dividend yield of 4%. Additionally, LCI's stock rose 32% over the past year, outperforming the S&P 500's 15% growth.

Read More